ReviewRSC advances2025

Disrupting the Hsp90-Cdc37 axis: a selective strategy for targeting oncogenic kinases in cancer.

Emadeldin M Kamel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.